Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net loss	$ (79,093)	$ (161,683)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,371	7,033
Stock-based compensation expense	3,211	6,599
Inventory impairments and option contract abandonments	11,071	28,145
Impairment of future land purchase right	0	4,036
Deferred and other income tax benefit	(36,378)	(185)
Provision for doubtful accounts	(1,678)	161
Excess tax benefit from equity-based compensation	64	544
Equity in loss of unconsolidated entities	62	141
Cash distributions of income from unconsolidated entities	0	38
Loss on extinguishment of debt	2,747	2,343
Changes in operating assets and liabilities:
Decrease in accounts receivable	9,381	301
Decrease in income tax receivable	2,425	4,849
Decrease (increase) in inventory	4,091	(150,612)
Decrease in other assets	5,442	3,391
Increase in trade accounts payable	778	15,803
Decrease in other liabilities	(37,813)	(38,012)
Other changes	(93)	(510)
Net cash used in operating activities	(106,412)	(277,618)
Cash flows from investing activities:
Capital expenditures	(15,117)	(12,134)
Investments in unconsolidated entities	(2,075)	(1,763)
Return of capital from unconsolidated entities	440	0
Increases in restricted cash	(1,679)	(250,074)
Decreases in restricted cash	6,955	4,950
Net cash used in investing activities	(11,476)	(259,021)
Cash flows from financing activities:
Repayment of debt	(3,369)	(213,755)
Proceeds from issuance of new debt	0	246,387
Proceeds from issuance of cash secured loan	0	247,368
Debt issuance costs	(274)	(5,130)
Equity issuance costs	(1,296)	0
Settlement of unconsolidated entity debt obligation	(15,862)	0
Common stock redeemed	(34)	(163)
Excess tax benefit from equity-based compensation	(64)	(544)
Net cash (used in) provided by financing activities	(20,899)	274,163
Decrease in cash and cash equivalents	(138,787)	(262,476)
Cash and cash equivalents at beginning of period	370,403	537,121
Cash and cash equivalents at end of period	$ 231,616	$ 274,645